EUVIMEDEUVIMED entdecken
Crossref

Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt/β-catenin signaling

Arisha Arora, Siddhartha Sankar Ghosh

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Arisha Arora und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Epithelial-Mesenchymal Transition, Wnt Signaling Pathway, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Electronics and Information technology, Department of Biotechnology, Ministry of Science and Technology, India, Indian Institute of Technology Guwahati.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) remains the most aggressive breast cancer subtype due to aberrant activation of EMT, predominantly driven by the Wnt/β-catenin signaling. Pigment epithelium-derived factor, a multifunctional protein and negative regulator of the Wnt pathway, is markedly downregulated in TNBC, providing an opportunity to restore the inhibition of this signaling axis for therapeutic benefit. In this study, we present a systematic method for the production of bioactive recombinant pigment epithelium-derived factor protein expressed in Escherichia coli BL21(DE3) and characterized by circular dichroism and MALDI-TOF analyses. Purified rPEDF treatment significantly inhibited the viability and stemness of EMT-induced TNBC cells and 3D spheroids, exhibiting IC50values of 0.15 and 0.11 µM in MDA-MB-231 and MDA-MB-468 monolayer cells, respectively. Mechanistically, rPEDF suppressed p-LRP6 and β-catenin levels, leading to reduced expression of downstream Wnt/β-catenin targets such as c-MYC, cyclin D1 and MMP-7, with synergistic inhibition when combined with a Wnt pathway inhibitor FH535. rPEDF treatment also suppressed the invasion and migratory capability of TNBC cells, with a 1.65-fold and 1.68-fold reduction in MDA-MB-231 and MDA-MB-468 cells, respectively. This effect was accompanied by concomitant downregulation of mesenchymal markers (Slug, Vimentin, Caveolin) and upregulation of epithelial markers, indicating successful reversal of EMT. Additionally, rPEDF treatment elevated intracellular ROS levels, triggering oxidative stress-mediated cytotoxicity in TNBC cells. Overall, our comprehensive findings establish rPEDF as a potent suppressor of EMT and Wnt-driven oncogenic signaling in TNBC, highlighting its promising potential as a recombinant protein to mitigate tumour metastasis and aggressiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsEpithelial-Mesenchymal TransitionWnt Signaling PathwayCell ProliferationEye ProteinsSerpinsbeta CateninIntercellular Signaling Peptides and ProteinsHumansDown-RegulationFemalePigment Epithelium-Derived FactorRecombinant ProteinsMDA-MB-231 CellsCell Line, Tumor

Stichwörter der Autor:innen

Wnt pathwaycancer stemnessepithelial to mesenchymal transition (EMT)protein therapeuticsrecombinant proteintriple negative breast cancer (TNBC)

Substanzen

Pigment Epithelium-Derived FactorRecombinant ProteinsEye ProteinsSerpinsbeta CateninIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
  • Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India; Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India. El…

Förderung

  • Ministry of Electronics and Information technology
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Institute of Technology Guwahati

Zitieren

APA

Arora, A., & Ghosh, S. S. (2026). Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt/β-catenin signaling. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118029

Vancouver

Arora A, Ghosh SS. Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt/β-catenin signaling. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118029

BibTeX
@article{Arora2026,
  author = {Arora, Arisha and Ghosh, Siddhartha Sankar},
  title = {Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt/β-catenin signaling},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118029}
}
Kostenlos starten →